Literature DB >> 9236442

Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results.

S Lévy1, P Ricard, M Gueunoun, F Yapo, J Trigano, C Mansouri, F Paganelli.   

Abstract

BACKGROUND: Recent studies have suggested that induced atrial fibrillation (AF) could be successfully terminated by using a two-catheter electrode system and low energy (< 400 V). This study evaluated the efficacy and safety of low-energy cardioversion in spontaneous chronic and paroxysmal AF. METHODS AND
RESULTS: Forty-two consecutive patients with spontaneous AF underwent low-energy electrical cardioversion. AF was chronic (> or = 1 month) with a mean duration of 9 +/- 19 months in 28 patients (group I) or paroxysmal with a history of recurrent attacks and a mean duration of the present episode of 7 +/- 16 days in 14 patients (group II). An underlying heart disease was present in 28 patients. A 3/3-ms biphasic shock was delivered between catheters positioned in the right atrium and the coronary sinus in 32 patients. In 10 patients, the left pulmonary artery branch was used. The catheters were connected to a custom external defibrillator. The shocks were synchronized to the R wave. Following a test shock of 60 V, the energy was increased in 40-V steps until a maximum of 400 V or restoration of sinus rhythm. Sinus rhythm was restored in 22 of the 28 patients (78%) of group I by using a mean leading-edge voltage of 297 +/- 57 V (mean energy 3.3 +/- 1.3 J) and in 11 of 14 patients (78%) of group II by using a mean leading-edge voltage of 223 +/- 41 V (mean energy, 1.8 +/- 0.7 J). The energy required for terminating chronic AF was significantly (P < .001) higher than that required for terminating paroxysmal AF. Among the other variables studied, the duration of AF significantly affected the successful voltage. Ventricular proarrhythmia occurred in 1 patient with atrial flutter due to an unsynchronized shock. Of the 22 patients of group I in whom sinus rhythm was restored, 14 (63%) remained in sinus rhythm with a mean follow-up of 9 +/- 3 months. Pain level showed a good correlation with increasing voltage. However, a marked inter-individual variation was noted.
CONCLUSIONS: Atrial defibrillation using low energy between two intracardiac catheters with an electrical field between the right and left atria and the protocol used is feasible in patients with persistent spontaneous AF. The technique is safe provided synchronization to the R wave is achieved. A low recurrence rate of AF was seen in patients in whom sinus rhythm was restored.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236442     DOI: 10.1161/01.cir.96.1.253

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.

Authors:  H F Tse; C P Lau; G M Ayers
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

Review 2.  Low-energy internal cardioversion of atrial fibrillation after failed external cardioversion: Texas Heart Institute experience and review of the literature.

Authors:  M Zaqqa; H Afshar; G R Khoshnevis; J A Lopez; A Massumi
Journal:  Tex Heart Inst J       Date:  1999

3.  Internal atrial and ventricular defibrillation during electrophysiology procedures.

Authors:  Fred M Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2005-08       Impact factor: 1.900

Review 4.  Internal defibrillation: where we have been and where we should be going?

Authors:  Samuel Lévy
Journal:  J Interv Card Electrophysiol       Date:  2005-08       Impact factor: 1.900

5.  Single shock endocavitary low energy intracardiac cardioversion of chronic atrial fibrillation.

Authors:  M Santini; C Pandozi; G Altamura; G Gentilucci; M Villani; M C Scianaro; A Castro; F Ammirati; B Magris
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

6.  A systematic evaluation of conventional and novel transvenous pathways for defibrillation.

Authors:  P R Roberts; S Allen; D C Smith; J F Urban; D E Euler; R W Dahl; M J Kallok; J M Morgan
Journal:  J Interv Card Electrophysiol       Date:  1999-10       Impact factor: 1.900

Review 7.  Is An Atrial Defibrillator Still An Option In Treating Patients With Atrial Fibrillation?

Authors:  Ziad El Khoury; Deepak Bhakta
Journal:  J Atr Fibrillation       Date:  2013-02-12

8.  Prevention of short term reversible chronic atrial fibrillation by permanent pacing at the triangle of Koch.

Authors:  L Padeletti; M C Porciani; A Michelucci; A Colella; A Costoli; C Ciapetti; P Pieragnoli; N Musilli; G F Gensini
Journal:  J Interv Card Electrophysiol       Date:  2000-12       Impact factor: 1.900

Review 9.  Atrial fibrillation: mechanisms, therapeutics, and future directions.

Authors:  Jason Pellman; Farah Sheikh
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

10.  Predictors of atrial fibrillation recurrence in patients with long-lasting atrial fibrillation.

Authors:  Michalis Efremidis; Ioannis P Alexanian; Dimitrios Oikonomou; Dimitrios Manolatos; Konstantinos P Letsas; Loukas K Pappas; Gerasimos Gavrielatos; Maria Vadiaka; Constantinos C Mihas; Gerasimos S Filippatos; Antonios Sideris; Fotios Kardaras
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.